Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
02/1996
02/29/1996DE4430128A1 Kombinationspräparat mit immunsuppressiven, kardiovaskulären und cerebralen Wirkungen Combination with immunosuppressive drug, cardiovascular and cerebral effects
02/29/1996DE4430091A1 Verwendung von N-substituierten Phenothiazinen Use of N-substituted phenothiazines
02/29/1996CA2198256A1 Use of n-substituted phenothiazines
02/29/1996CA2198242A1 Pyrrolidinyl di-carboxylic acid derivatives as metabotropic glutamate receptor antagonists
02/29/1996CA2198108A1 Methods of maintaining teeth and oral bone
02/29/1996CA2198016A1 Methods of inhibiting ulcerative mucositis
02/28/1996EP0698109A1 Gene transfer into pancreatic and biliary epithelial cells
02/28/1996EP0698014A1 3-phenylureido-1,5-benzodiazepine-diones useful as gastrin or cck antagonists
02/28/1996EP0697888A1 Conserved motif of hepatitis c virus e2/ns1 region
02/28/1996EP0697877A1 Psyllium drink mix compositions
02/28/1996EP0697873A1 Olefin-substituted long chain compounds
02/28/1996EP0697868A1 Methods and compositions using optically pure (+)-zileuton
02/28/1996EP0661966A4 Ulcer prevention and treatment composition and method.
02/28/1996EP0494978B1 Heterocyclic compounds
02/28/1996EP0362367B1 Osteogenic devices
02/28/1996CN1117743A Method to predict active growth of bacteria adhered to a surface
02/28/1996CN1117727A Indolin-2-one derivative
02/28/1996CN1117492A Treatment of H. pylori infections
02/28/1996CN1117385A Medicinal granules for treating pediatric anorexia
02/27/1996US5494928 Indole derivatives
02/27/1996US5494907 11-β substituted-19-nor steroids
02/27/1996US5494894 Using a pentapeptide
02/27/1996US5494665 Metal chloride, lysozyme chloride, isotonic agent, nonionic thickening agent and preservative
02/27/1996US5494664 Bifidobacteria
02/27/1996CA2155447A1 Substituted biphenyl isoxazole sulfonamides
02/22/1996WO1996005320A1 Adenovirus comprising a gene coding for glutathion peroxidase
02/22/1996WO1996005297A1 Method of gene therapy using dna vectors without selection marker gene
02/22/1996WO1996005221A1 Calcitonin receptor
02/22/1996WO1996005203A1 Spiro-substituted azacyclic derivatives and their use as therapeutic agents
02/22/1996WO1996005193A1 (azetidin-1-ylalkyl)lactams as tachykinin antagonists
02/22/1996WO1996005187A1 (4-(3-aminomethylphenyl)thiazol-2-yl)-guanidines as h2-receptor antagonists
02/22/1996WO1996005181A1 Morpholine derivatives and their use as therapeutic agents
02/22/1996WO1996005177A1 Novel pyrimidine derivatives and processes for the preparation thereof
02/22/1996WO1996004933A2 Cck antibodies used to improve feed efficiency
02/22/1996WO1996004930A1 Transferrin compositions to alleviate the side effects of cytotoxic drugs
02/22/1996WO1996004928A1 Calcitonin gene related peptide receptor
02/22/1996WO1996004914A1 Triazine derivative and medicine
02/22/1996CA2197091A1 Triazine derivative and medicine
02/22/1996CA2196594A1 Use of antibodies to cck to improve feed efficiency
02/22/1996CA2195972A1 Morpholine derivatives and their use as therapeutic agents
02/22/1996CA2195757A1 Spiro-substituted azacyclic derivatives and their use as therapeutic agents
02/21/1996EP0697403A1 Derivatives of glycinamides as cholecystokinin receptor agonists
02/21/1996EP0696921A1 Veterinary composition containing a proton pump inhibitor
02/21/1996EP0559746B1 Compositions containing psyllium
02/21/1996CN1116945A Capsule for gastric diseases
02/20/1996US5492927 Non-peptide tachykinin receptor antagonists to treat allergy
02/20/1996US5492914 2-(1-azabicyclo[2.2.2]oct-3 s-yl)-6-hydroxy-2,4,5,6-tetrahydro-1H-benz[DE]is[2.2.2]oct-3's-yl)-6-hydroxy-2,3,3a,4,5,6-hexahydro-1h-benz [DE]isoquinolin-1-one and individual stereoisomers thereof
02/20/1996US5492906 Derivatives of thieno-triazolo-diazepine and therapeutic compositions containing them
02/20/1996US5492891 Treating with human growth hormone to increase levels of insulin-like growth factor
02/20/1996CA2155134A1 Branched polysaccharide, microorganism producing it and compositions containing them
02/20/1996CA2029015C Pharmaceutical compositions for treating gastrointestinal distress
02/15/1996WO1996004385A2 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
02/15/1996WO1996004280A1 Phenyl xanthine derivatives
02/15/1996WO1996004254A2 Benzodiazepine derivatives
02/15/1996WO1996004250A1 Benzimidazole derivatives having dopaminergic activity
02/15/1996WO1996004233A1 Aryloxy and arylthiopropanolamine derivatives useful as beta 3-adrenoreceptor agonists and antagonists of the beta 1 and beta 2-adrenoreceptors and pharmaceutical composition thereof
02/15/1996WO1996003983A1 Inhibition of leukotriene biosynthesis with urea derivatives
02/15/1996WO1995031991A3 Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases
02/15/1996DE4428402A1 Gentherapeutisches Verfahren unter Verwendung von DNA-Vektoren ohne Selektionsmarker-Gen Gene therapy methods using DNA vectors without selectable marker gene
02/15/1996CA2196701A1 Inhibition of leukotriene biosynthesis with urea derivatives
02/15/1996CA2196193A1 Aryloxy and arylthiopropanolamine derivatives useful as beta 3-adrenoreceptor agonists and antagonists of the beta 1 and beta 2-adrenoreceptors and pharmaceutical composition thereof
02/15/1996CA2196062A1 Benzodiazepine derivatives
02/15/1996CA2195312A1 Novel hepatitis c e1 and e2 truncated polypeptides and methods of obtaining the same
02/15/1996CA2172273A1 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
02/14/1996EP0696640A2 Recombinant antigen from the NS3 region of hepatitis C virus
02/14/1996EP0696578A2 Polyamines and polypeptides useful as antagonists of excitatory amino acid neurotransmitters and/or blockers of calcium channels
02/14/1996EP0696455A1 Transferrin compositions to alleviate the side effects of cytotoxic drugs
02/14/1996EP0696281A1 Novel 5-pyrrolyl-2-pyridylmethylsulfinyl benzimidazole derivatives
02/14/1996EP0696272A1 Cyclooxygenase and 5-lipoxygenase inhibiting n(3-biphenylyl-1(s)-methyl-2-propenyl) acetohydroxamic acid derivatives
02/14/1996EP0696271A1 Cyclooxygenase and 5-lipoxygenase inhibiting hydroxamic acid derivatives
02/14/1996EP0696199A1 Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes
02/14/1996CN1116544A Traditional Chinese medicine for relaxing liver and strengthening stomach
02/13/1996US5490988 Delivery of therapeutic agents to a target site
02/13/1996US5490984 Injecting wound healing agents into defective area
02/08/1996WO1996003405A1 Imidazopyridine-azolidinones
02/08/1996WO1996003404A1 Acyl imidazopyridines
02/08/1996WO1996003403A1 Benzyl-imidazopyridines
02/08/1996WO1996003402A1 Halogenated imidazopyridines
02/08/1996WO1996003399A1 Dihydrobenzofuranes
02/08/1996WO1996003383A1 INDOLIZINE sPLA2 INHIBITORS
02/08/1996WO1996003376A1 1H-INDOLE-1-FUNCTIONAL sPLA2 INHIBITORS
02/08/1996WO1996003140A1 HLA binding peptides and their uses
02/08/1996CA2196078A1 Imidazopyridine-azolidinones
02/08/1996CA2196077A1 Benzyl-imidazopyridines
02/08/1996CA2196076A1 Acyl imidazopyridines
02/08/1996CA2196075A1 Halogenated imidazopyridines
02/08/1996CA2195671A1 Hla binding peptides and their uses
02/08/1996CA2195570A1 Indolizine spla2 inhibitors
02/08/1996CA2195569A1 1h-indole-1-functional spla2 inhibitors
02/07/1996EP0695546A1 Powders based on metoclopramide and paracetamol or acetylsalicylic acid derivatives
02/07/1996EP0695303A1 New pyridinium salts and their use for controlling helicobacter bacteria
02/07/1996EP0695297A1 1,5-benzodiazepines useful as gastrin or cck-antagonists
02/07/1996EP0695123A1 Methods and compositions for treating gastric disorders using optically pure (-) pantoprazole
02/07/1996EP0671930A4 Prophylaxis and treatment of adverse oral conditions with biologically active peptides.
02/07/1996CN1116103A Traditional Chinese powder medicine for dog diseases
02/06/1996US5489609 Liver disorder, hepatitis, antiulcer agent
02/06/1996US5489604 Treating degenerative diseases
02/06/1996US5489576 Therapeutic agent for hemorrhoidal diseases
02/06/1996US5489530 Active at ph 3.5-9.0 and not inhibited by sodium deoxycholate; used for producing drugs for therapy of maldigestion
02/01/1996WO1996002559A1 Growth differentiation factor-12
1 ... 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 ... 1258